<?xml version="1.0" encoding="UTF-8"?>
<p> The protocol is written very well and the end points and analysis are formulated clearly. The purpose of these two trials is clear and the results will provide a very important contribution to the policy on the use of fractional dose yellow fever vaccine in adults, children and hiv-infected persons.</p>
